Table 6.
Variables | Univariate analysis |
Multivariate analysis |
||
---|---|---|---|---|
p | OR (95% CI) | p | OR (95% CI) | |
ALOX12 | .010 | 1.059–1.535 | .046 | 1.007–2.186 |
eGFR | .040 | 0.941–0.999 | – | – |
ALB | .024 | 0.799–0.984 | – | – |
TC | .008 | 1.244–4.208 | – | – |
HDLC | .037 | 1.193–268.120 | – | – |
LDLC | .012 | 1.187–3.891 | – | – |
Apo A | .048 | 1.028–947.893 | – | – |
Apo B | .002 | 10.822–35518.698 | – | – |
U-RBP | .009 | 1.093–1.869 | – | – |
U-CYC | .033 | 1.210–93.704 | – | – |
|
.009 | 0.628–0.937 | .052 | 0.564–1.002 |
Glomerular lesions | .000 | 2.257–17.542 | .005 | 1.751–23.723 |
Arteriolar hyalinosis | .038 | 1.076–12.789 | – | – |
IFTA | .004 | 1.831–24.649 | – | – |
eGFR: estimated glomerular filtration rate; ALB: albumin; TC: total cholesterol; TG: triglyceride; HDLC: high-density lipoprotein cholesterol; LDLC: low-density lipoprotein cholesterol; Apo A: apolipoprotein A; Apo B: apolipoprotein B; U-RBP: urinary retinol-binding protein; U-CYC: urinary cystatin c; U-Cr: urinary creatinine; IFTA: interstitial fibrosis and tubular atrophy.